Jasper Therapeutics (JSPRW) Short Interest Ratio & Short Volume $0.10 -0.01 (-10.56%) As of 04/24/2025 09:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock Jasper Therapeutics Short Interest DataJasper Therapeutics (JSPRW) has a short interest of 17,800 shares. This marks a -0.56% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.8, indicating that it would take 2.8 days of the average trading volume of 7,227 shares to cover all short positions.Current Short Interest17,800 sharesPrevious Short Interest17,900 sharesChange Vs. Previous Month-0.56%Dollar Volume Sold Short$2,403.00Short Interest Ratio2.8 Days to CoverLast Record DateMarch 31, 2025Today's Trading Volume5,900 sharesAverage Trading Volume7,227 sharesToday's Volume Vs. Average82% Short Selling Jasper Therapeutics? Sign up to receive the latest short interest report for Jasper Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartJSPRW Short Interest Over TimeJSPRW Days to Cover Over TimeJSPRW Percentage of Float Shorted Over Time Jasper Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202517,800 shares $2,403.00 -0.6%N/A2.8 $0.14 3/15/202517,900 shares $2,593.71 -2.2%N/A3 $0.14 2/28/202518,300 shares $2,324.10 +1.7%N/A3.1 $0.13 2/15/202518,000 shares $2,610.00 +7.1%N/A3.1 $0.15 1/31/202516,800 shares $2,486.40 -11.1%N/A2.7 $0.15 1/15/202518,900 shares $2,835.00 +11.8%N/A3.2 $0.15 12/31/202416,900 shares $3,542.24 +1.8%N/A4.3 $0.21 12/15/202416,600 shares $3,685.20 +5.7%N/A6.4 $0.22 11/30/202415,700 shares $3,136.86 -4.3%N/A3.8 $0.20 11/15/202416,400 shares $3,050.38 -18.0%N/A3.3 $0.19 Get the Latest News and Ratings for JSPRW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/202420,000 shares $3,996.00 +13.0%N/A4.3 $0.20 10/15/202417,700 shares $3,251.49 +1.7%N/A3.8 $0.18 9/30/202417,400 shares $3,480.00 -44.2%N/A3.8 $0.20 9/15/202431,200 shares $5,850.00 +45.8%N/A6.6 $0.19 8/31/202421,400 shares $4,641.66 +34.6%N/A5 $0.22 8/15/202415,900 shares $3,339.00 +51.4%N/A5.9 $0.21 7/31/202410,500 shares $2,283.75 +5.0%N/A2.7 $0.22 7/15/202410,000 shares $2,098.99 -1.0%N/A1.3 $0.21 6/30/202410,100 shares $2,020.00 +21.7%N/A0.8 $0.20 6/15/20248,300 shares $1,722.25 -3.5%N/A0.5 $0.21 5/31/20248,600 shares $1,676.14 +126.3%N/A0.5 $0.19 5/15/20243,800 shares $731.50 -19.2%N/A0.2 $0.19 4/30/20244,700 shares $674.45 -36.5%N/A0.2 $0.14 4/15/20247,400 shares $1,250.60 -8.6%N/A0.3 $0.17 3/31/20248,100 shares $1,474.20 -29.0%N/A0.3 $0.18 3/15/202411,400 shares $1,827.42 -10.9%N/A0.4 $0.16 2/29/202412,800 shares $2,842.88 +0.8%N/A0.5 $0.22 2/15/202412,700 shares $2,286.00 +71.6%N/A0.6 $0.18 1/31/20247,400 shares $740.00 -66.4%N/A0.3 $0.10 1/15/202422,000 shares $1,757.80 -8.3%N/A1 $0.08 12/31/202324,000 shares $1,920.00 +124.3%N/A1.1 $0.08 12/15/202310,700 shares $700.85 -2.7%N/A0.5 $0.07 11/30/202311,000 shares $873.40 -7.6%N/A0.5 $0.08 11/15/202311,900 shares $595.00 +56.6%N/A0.6 $0.05 10/31/20237,600 shares $836.00 -26.2%N/A0.4 $0.11 10/15/202310,300 shares $1,184.50 +51.5%N/A0.8 $0.12 9/30/20236,800 shares $340.00 +47.8%N/A0.5 $0.05 9/15/20234,600 shares $471.96 +18.0%N/A0.9 $0.10 8/31/20233,900 shares $236.34 -45.8%N/A0.8 $0.06 8/15/20237,200 shares $732.24 -20.9%N/A0.7 $0.10URGENT: Someone's Moving Gold Out of London... (Ad)People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold. Go here to learn about my Top Four picks for the coming bull mania. 7/31/20239,100 shares $910.00 -49.4%N/A1 $0.10 7/15/202318,000 shares $2,407.73 -2.7%N/A1.9 $0.13 6/30/202318,500 shares $2,594.61 -7.0%N/A1.9 $0.14 6/15/202319,900 shares $2,889.48 -21.7%N/A1.5 $0.15 5/31/202325,400 shares $3,550.92 -0.4%N/A1.2 $0.14 5/15/202325,500 shares $4,204.95 No ChangeN/A1.1 $0.16 JSPRW Short Interest - Frequently Asked Questions What is Jasper Therapeutics' current short interest? Short interest is the volume of Jasper Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 17,800 shares of JSPRW short. Learn More on Jasper Therapeutics' current short interest. What is a good short interest ratio for Jasper Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. JSPRW shares currently have a short interest ratio of 3.0. Learn More on Jasper Therapeutics's short interest ratio. Is Jasper Therapeutics' short interest increasing or decreasing? Jasper Therapeutics saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 17,800 shares, a decrease of 0.6% from the previous total of 17,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Jasper Therapeutics stock? Short selling JSPRW is an investing strategy that aims to generate trading profit from Jasper Therapeutics as its price is falling. JSPRW shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Jasper Therapeutics? A short squeeze for Jasper Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of JSPRW, which in turn drives the price of the stock up even further. How often is Jasper Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JSPRW, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies ALVOW Short Interest BCTXW Short Interest CLNNW Short Interest ENGNW Short Interest FBIOP Short Interest IMTXW Short Interest LEXXW Short Interest LIXTW Short Interest NLSPW Short Interest NRXPW Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:JSPRW) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jasper Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.